Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes

AIDS. 2000 Jan 7;14(1):1-9. doi: 10.1097/00002030-200001070-00001.

Abstract

Objective: To develop an HIV-1 accessory gene immunogen using a DNA vaccine approach.

Methods: HIV-1 accessory genes vif, vpu and nef were modified to express under the control of a single promoter with cellular proteolytic cleavage sites between the coding sequences (VVN-P). Immune responses induced by these constructs were evaluated in mice.

Results: DNA vaccine construct (pVVN-P) expressing Vif, Vpu and Nef was processed and the fusion protein was cleaved appropriately. Vif, Vpu and Nef as a fusion protein with proteolytic cleavage sites (VVN-P) is able to induce a significant level of cellular immune responses. We also observed that accessory genes Vif, Vpu and Nef (VVN-P) induced an effective T helper 1 proliferative response measured by cytokine production. Furthermore, expression cassette pVVN-P was able to induce cytotoxic T lymphocyte (CTL) responses against diverse HIV-1 viruses in infected target cells.

Conclusion: We conclude that cell-mediated immune responses induced by accessory gene constructs from clade B may have a broader recognition of divergent HIV-1 viruses and should be further examined for both prophylactic and therapeutic vaccination schemes against HIV-1.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3T3 Cells
  • Animals
  • Blotting, Western
  • Cell Division / immunology
  • Cells, Cultured
  • Cytokines / biosynthesis
  • Cytotoxicity Tests, Immunologic
  • Fluorescent Antibody Technique
  • Gene Products, nef / genetics
  • Gene Products, nef / immunology
  • Gene Products, nef / metabolism
  • Gene Products, vif / genetics
  • Gene Products, vif / immunology
  • Gene Products, vif / metabolism
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • HIV-1 / isolation & purification
  • HeLa Cells
  • Human Immunodeficiency Virus Proteins
  • Humans
  • Injections, Intramuscular
  • Mice
  • Mice, Inbred BALB C
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / immunology
  • Recombinant Fusion Proteins / metabolism
  • T-Lymphocytes, Helper-Inducer / cytology
  • T-Lymphocytes, Helper-Inducer / metabolism
  • Transfection
  • Vaccination
  • Vaccines, DNA / genetics
  • Vaccines, DNA / immunology*
  • Vaccines, DNA / metabolism
  • Viral Regulatory and Accessory Proteins / genetics
  • Viral Regulatory and Accessory Proteins / immunology
  • Viral Regulatory and Accessory Proteins / metabolism
  • nef Gene Products, Human Immunodeficiency Virus
  • vif Gene Products, Human Immunodeficiency Virus

Substances

  • Cytokines
  • Gene Products, nef
  • Gene Products, vif
  • Human Immunodeficiency Virus Proteins
  • Recombinant Fusion Proteins
  • Vaccines, DNA
  • Viral Regulatory and Accessory Proteins
  • nef Gene Products, Human Immunodeficiency Virus
  • vif Gene Products, Human Immunodeficiency Virus
  • vpu protein, Human immunodeficiency virus 1